Muscle Damage and Disuse Atrophy

September 20, 2021 updated by: University of Exeter

In Young Healthy Males and Females, What is the Effect of Prior Eccentric Exercise on Thigh Muscle Atrophy During One Week of Leg Disuse Compared to no Prior Exercise?

Limb injury generally requires a period of recovery during which time the limb is often immobilised (e.g. with a cast or brace) resulting in a rapid loss of skeletal muscle. Despite the importance of muscle loss during injury, our understanding of how it occurs is incomplete. Several factors are likely to contribute, including a lack of muscle contraction and injury induced inflammation. In this study, the investigators will recruit healthy volunteers who will spend 7 days in a knee brace to replicate leg immobilisation. Prior to immobilisation, half of the participants will perform a single session of strenuous resistance exercise which is known to cause muscle damage and initiate an inflammatory response. This is designed to replicate the muscle damage and inflammation that occurs with injury. The remaining half of participants will not perform this exercise, allowing us to look at the additive effect of muscle damage and inflammation on muscle loss with immobilisation.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Devon
      • Exeter, Devon, United Kingdom, EX1 2LU
        • University of Exeter

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged 18 - 40
  • BMI between 18 and 27
  • Healthy, recreationally active, non smoker

Exclusion Criteria:

  • Non-removable metallic implants (including heart pacemaker, cochlear implants, medication pumps, surgical clips, plates or screws) or claustrophobia
  • Use of nutritional supplements
  • Chronic use of over the counter medication
  • Any diagnosed metabolic disease (e.g. type 1 or 2 Diabetes).
  • Any diagnosed cardiovascular disease or hypertension.
  • Anyone with previous motor disorders. Anyone with a current musculoskeletal injury that may impair their use of crutches.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Immobilisation without prior exercise
Experimental: Muscle damage
300 bilateral knee extensor eccentric contraction performed immediately prior to immobilisation
300 eccentric contractions of the knee extensors

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in thigh muscle volume from pre-immobilisation
Time Frame: After 2 days of immobilisation
The volume of the muscles comprising the thigh after 2 days of immobilisation will be compared to pre-immobilisation values. This will be measured using MRI.
After 2 days of immobilisation
Change in thigh muscle volume from pre-immobilisation
Time Frame: After 7 days of immobilisation
The volume of the muscles comprising the thigh after 7 days of immobilisation will be compared to pre-immobilisation values, and values obtained after 2 days of immobilisation. This will be measured using MRI.
After 7 days of immobilisation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in unilateral knee extensor 1 repetition maximum
Time Frame: After 7 days of immobilisation
Unilateral knee extensor 1 repetition maximum will be measured before and after 7 days of single leg immobilisation using a weight stack leg extension machine
After 7 days of immobilisation
Change in unilateral knee extensor maximal voluntary torque production
Time Frame: After 7 days of immobilisation
Unilateral knee extensor maximal voluntary torque production will be measured before and after 7 days of single leg immobilisation using an isokinetic dynamometer.
After 7 days of immobilisation
Change in unilateral knee extensor isokinetic total work
Time Frame: After 7 days of immobilisation
Unilateral knee extensor total isokinetic work after 30 consecutive contractions will be measured before and after 7 days of single leg immobilisation using an isokinetic dynamometer.
After 7 days of immobilisation
Muscle protein synthesis assessed using the stable isotope Deuterium Oxide
Time Frame: After 2 days of immobilisation
The enrichment of deuterated alanine (from the deuterium oxide heavy water stable isotope tracer) in vastus lateralis biopsy samples will be measured relative to the non-deuterated alanine. The change between pre-immobilisation and 2 days of immobilisation will be used to calculated a fractional synthetic rate (% day).
After 2 days of immobilisation
Muscle protein synthesis assessed using the stable isotope Deuterium Oxide
Time Frame: After 7 days of immobilisation
The enrichment of deuterated alanine (from the deuterium oxide heavy water stable isotope tracer) in vastus lateralis biopsy samples will be measured relative to the non-deuterated alanine. The change between pre-immobilisation and 7 days of immobilisation will be used to calculated a fractional synthetic rate (% day).
After 7 days of immobilisation
Change in skeletal muscle gene expression
Time Frame: After 2 days of immobilisation
Skeletal muscle gene expression will be measured before and after 2 days of single leg immobilisation.
After 2 days of immobilisation
Change in skeletal muscle gene expression
Time Frame: After 7 days of immobilisation
Skeletal muscle gene expression will be measured before and after 7 days of single leg immobilisation.
After 7 days of immobilisation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2018

Primary Completion (Actual)

October 31, 2019

Study Completion (Actual)

October 31, 2019

Study Registration Dates

First Submitted

May 31, 2018

First Submitted That Met QC Criteria

June 13, 2018

First Posted (Actual)

June 18, 2018

Study Record Updates

Last Update Posted (Actual)

September 27, 2021

Last Update Submitted That Met QC Criteria

September 20, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muscle Disuse Atrophy

Clinical Trials on Eccentric exercise

Subscribe